Fox Run Management’s Amylyx Pharmaceuticals AMLX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-11,788
| Closed | -$44.6K | – | 893 |
|
|
2024
Q4 | $44.6K | Buy |
+11,788
| New | +$44.6K | 0.01% | 828 |
|
|
2024
Q1 | – | Sell |
-22,007
| Closed | -$324K | – | 735 |
|
|
2023
Q4 | $324K | Buy |
22,007
+5,022
| +30% | +$73.9K | 0.08% | 467 |
|
|
2023
Q3 | $311K | Sell |
16,985
-1,007
| -6% | -$18.4K | 0.09% | 431 |
|
|
2023
Q2 | $388K | Buy |
17,992
+5,494
| +44% | +$119K | 0.11% | 356 |
|
|
2023
Q1 | $367K | Buy |
+12,498
| New | +$367K | 0.12% | 337 |
|